search
Back to results

Indoor Air Pollution and Children With Asthma: An Intervention Trial (CAPS)

Primary Purpose

Asthma

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
NO2 Scrubber
HEPA filter
Control
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthma focused on measuring Nitrogen Dioxide, Parts per billion

Eligibility Criteria

5 Years - 11 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 5-11 years of age, enrolled in grades K-5 and living in the recruitment area (CT, MA)
  • [The screening questionnaire will determine asthma symptoms in the past 12 months (wheeze, persistent cough, shortness of breath, chest tightness); and asthma medication use in the past 12 months (short-acting β2-agonists, long-acting β2-agonists, inhaled steroids, oral steroids, theophylline, cromones, and/or leukotriene inhibitors). Based on symptoms and medication, asthma severity will be categorized with a score adapted from the Global Initiative for Asthma guidelines (1=mild transient, 2=mild persistent, 3=moderate, 4=severe). Only children in categories 2 (mild persistent, 3 (moderate) or 4 (severe) will be eligible.]
  • For potential subjects satisfying these inclusion criteria, a passive NO2 monitor will be sent to the home for placement in the main living space for one week. Families will be called after one week and instructed to cap and return the NO2 monitor in a pre-paid mailer. Families of children living in homes where the one-week integrated average NO2 concentration is ≥ 15 ppb will be invited to participate. We will permit the enrollment of more than one eligible child per family.

Exclusion Criteria:

  • Using steroid medication for a condition other than asthma
  • Chronic respiratory condition other than asthma
  • Intention to move or relocate within 6 months

Sites / Locations

  • Yale University

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

NO2 Scrubber, then HEPA filter, then Control

NO2 Scrubber, then Control, then HEPA filter

HEPA filter, then NO2 scrubber, then Control

HEPA filter, then Control, then NO2 scrubber

Control, then HEPA filter, then NO2 scrubber

Control, then NO2 scrubber, then HEPA filter

Arm Description

Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of NO2 Scrubber, then HEPA filter, then Control.

Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of NO2 Scrubber, then Control, then HEPA filter

Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of HEPA filter, then NO2 scrubber, then Control

Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of HEPA filter, then Control, then NO2 scrubber

Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of Control, then HEPA filter, then NO2 scrubber

Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of Control, then NO2 scrubber, then HEPA filter

Outcomes

Primary Outcome Measures

Days with symptoms
The maximum of the following variables reported over the 2-week recall period: (1) number of days with wheezing, chest tightness, or persistent cough; (2) number of nights of sleep disturbance; (3) number of days when activities were affected.

Secondary Outcome Measures

Days of wheeze
As measured by self report
Night symptoms
As measured by self report
Rescue medication use
As measured by self report
Symptom Score
The score is adapted from the Global Initiative for Asthma Guidelines which incorporates type and frequency of symptoms and medications. The symptom score portion, is a 5-level score calculated based on symptoms during the last 4-weeks of the intervention.
Amount of Restricted Activity
Activity Restrictions as measured by self report
Number of Missed days of school
As measured by self report
Number of Hospitalizations
As measured by self report
Number of Emergency Room Visits
As measured by self report
Number of Doctors Visits
As measured by self report

Full Information

First Posted
October 2, 2014
Last Updated
November 19, 2020
Sponsor
Yale University
Collaborators
Harvard University, National Institute of Environmental Health Sciences (NIEHS)
search

1. Study Identification

Unique Protocol Identification Number
NCT02258893
Brief Title
Indoor Air Pollution and Children With Asthma: An Intervention Trial
Acronym
CAPS
Official Title
Indoor Nitrogen Dioxide Exposure and Children With Asthma: An Intervention Trial
Study Type
Interventional

2. Study Status

Record Verification Date
November 2020
Overall Recruitment Status
Completed
Study Start Date
January 1, 2016 (Actual)
Primary Completion Date
August 31, 2019 (Actual)
Study Completion Date
August 31, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
Harvard University, National Institute of Environmental Health Sciences (NIEHS)

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether reducing indoor exposure to NO2 and particles improves respiratory health in children with asthma.
Detailed Description
We have designed a randomized, double-blind, triple cross-over intervention study to examine the efficacy of indoor NO2 reduction on reducing asthma severity. Since particles and NO2 are both byproducts of combustion and associated with gas stove use, the intervention protocol includes a condition using a filter designed to remove particles also implicated in asthma exacerbations (e.g., coarse, fine and ultrafine particles including airborne mold spores and allergens) while leaving NO2 virtually untouched. Primary and secondary aims of the trial include, respectively, determining whether reducing exposure to NO2 and particles compared to a "control" (non-filtered) condition results in a clinically significant reduction in asthma severity measured by a difference in days of symptoms between intervention arms. Families with asthmatic children age 5-11 will be recruited from selected communities using a: (1) flyers distributed in elementary schools, (2) postcards send to families from purchased mailing lists, (3) posters placed in community buildings (libraries, clinics, etc.), (4) online (Facebook, Craigslist), and (5) letter mailed to families targeted through Yale Joint Data Analytics Team (JDAT). Volunteers will be screened for preliminary eligibility based on household characteristics and active asthmatic status. Potentially eligible families will have homes with a gas cooking stove and seven rooms or fewer. Potentially eligible children will be aged 5-11; have asthma symptoms and/or medication use consistent with severity score categories 2 (mild persistent), 3 (moderate), or 4 (severe) during the previous 12 months; and reside at least 5 days and nights every week in the eligible home. Households meeting these preliminary criteria will be asked to participate in passive NO2 sampling. A single Palmes tube will be sent to the home for placement in the main living space for one week. Families will be called after one week and instructed to cap and return the NO2 monitor in a pre-paid mailer. Families of children living in homes where the one-week integrated average NO2 concentration is ≥ 15 ppb will be invited to participate. We will permit enrollment of more than one eligible child per family. Participating families will be randomized into one of 6 treatment sequences each requiring 3 periods of 4-weeks preceded by a 1-week washout period. Randomization will be blocked so that for every 18 subjects randomized there will be 3 in each sequence. Randomization will be conducted blindly by the data management department such that each scheduled initial interview/air cleaner installation is assigned a treatment sequence (referring to machines and filters already on site). Minimization techniques will be used to balance the randomized allocation as necessary. Total subject participation time up to 18 weeks.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Nitrogen Dioxide, Parts per billion

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
116 (Actual)

8. Arms, Groups, and Interventions

Arm Title
NO2 Scrubber, then HEPA filter, then Control
Arm Type
Experimental
Arm Description
Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of NO2 Scrubber, then HEPA filter, then Control.
Arm Title
NO2 Scrubber, then Control, then HEPA filter
Arm Type
Experimental
Arm Description
Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of NO2 Scrubber, then Control, then HEPA filter
Arm Title
HEPA filter, then NO2 scrubber, then Control
Arm Type
Experimental
Arm Description
Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of HEPA filter, then NO2 scrubber, then Control
Arm Title
HEPA filter, then Control, then NO2 scrubber
Arm Type
Experimental
Arm Description
Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of HEPA filter, then Control, then NO2 scrubber
Arm Title
Control, then HEPA filter, then NO2 scrubber
Arm Type
Experimental
Arm Description
Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of Control, then HEPA filter, then NO2 scrubber
Arm Title
Control, then NO2 scrubber, then HEPA filter
Arm Type
Experimental
Arm Description
Participants will have 3 periods of 4 weeks with each filter with a 1 week washout between phases in the order of Control, then NO2 scrubber, then HEPA filter
Intervention Type
Other
Intervention Name(s)
NO2 Scrubber
Intervention Description
an NO2 scrubber that removes NO2 and particles
Intervention Type
Other
Intervention Name(s)
HEPA filter
Intervention Description
a HEPA filter that removes 95% of suspended particles ≥ 0.003 μm in size (but does not remove NO2)
Intervention Type
Other
Intervention Name(s)
Control
Intervention Description
a "control" filter designed to be the same size and weight as the other two filters, but filters neither NO2 nor particles
Primary Outcome Measure Information:
Title
Days with symptoms
Description
The maximum of the following variables reported over the 2-week recall period: (1) number of days with wheezing, chest tightness, or persistent cough; (2) number of nights of sleep disturbance; (3) number of days when activities were affected.
Time Frame
Final 14 days of intervention
Secondary Outcome Measure Information:
Title
Days of wheeze
Description
As measured by self report
Time Frame
Post 4 week intervention
Title
Night symptoms
Description
As measured by self report
Time Frame
Post 4 week intervention
Title
Rescue medication use
Description
As measured by self report
Time Frame
Post 4 week intervention
Title
Symptom Score
Description
The score is adapted from the Global Initiative for Asthma Guidelines which incorporates type and frequency of symptoms and medications. The symptom score portion, is a 5-level score calculated based on symptoms during the last 4-weeks of the intervention.
Time Frame
Last 4 weeks of intervention
Title
Amount of Restricted Activity
Description
Activity Restrictions as measured by self report
Time Frame
Post 4 week intervention
Title
Number of Missed days of school
Description
As measured by self report
Time Frame
Post 4 week intervention
Title
Number of Hospitalizations
Description
As measured by self report
Time Frame
Post 4 week intervention
Title
Number of Emergency Room Visits
Description
As measured by self report
Time Frame
Post 4 week intervention
Title
Number of Doctors Visits
Description
As measured by self report
Time Frame
Post 4 week intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
11 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 5-11 years of age, enrolled in grades K-5 and living in the recruitment area (CT, MA) [The screening questionnaire will determine asthma symptoms in the past 12 months (wheeze, persistent cough, shortness of breath, chest tightness); and asthma medication use in the past 12 months (short-acting β2-agonists, long-acting β2-agonists, inhaled steroids, oral steroids, theophylline, cromones, and/or leukotriene inhibitors). Based on symptoms and medication, asthma severity will be categorized with a score adapted from the Global Initiative for Asthma guidelines (1=mild transient, 2=mild persistent, 3=moderate, 4=severe). Only children in categories 2 (mild persistent, 3 (moderate) or 4 (severe) will be eligible.] For potential subjects satisfying these inclusion criteria, a passive NO2 monitor will be sent to the home for placement in the main living space for one week. Families will be called after one week and instructed to cap and return the NO2 monitor in a pre-paid mailer. Families of children living in homes where the one-week integrated average NO2 concentration is ≥ 15 ppb will be invited to participate. We will permit the enrollment of more than one eligible child per family. Exclusion Criteria: Using steroid medication for a condition other than asthma Chronic respiratory condition other than asthma Intention to move or relocate within 6 months
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brian Leaderer, PhD, MPH
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Michael Bracken, PhD MPH FACE
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Theodore Holford, PhD
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Janneane Gent, PhD
Organizational Affiliation
Yale University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale University
City
New Haven
State/Province
Connecticut
ZIP/Postal Code
06520
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
35796019
Citation
Gent JF, Holford TR, Bracken MB, Plano JM, McKay LA, Sorrentino KM, Koutrakis P, Leaderer BP. Childhood asthma and household exposures to nitrogen dioxide and fine particles: a triple-crossover randomized intervention trial. J Asthma. 2023 Apr;60(4):744-753. doi: 10.1080/02770903.2022.2093219. Epub 2022 Jul 7.
Results Reference
derived

Learn more about this trial

Indoor Air Pollution and Children With Asthma: An Intervention Trial

We'll reach out to this number within 24 hrs